Thus, siFoxM1-Apt-CNBs combined with UMND gene therapy can improve both the transfection efficiency and the efficiency of gene delivery, which would meet the ultimate goal of tumor therapy. The gene discussed is LYPLA2P1; the disease is neoplasm.